Evidence map›Paper›PMID 35190617›Full record

ArticleScientific reports2022

Association of lipid rafts cholesterol with clinical profile in fragile X syndrome.

Amanda Toupin, Sérine Benachenhou, Armita Abolghasemi, Asma Laroui, Luc Galarneau, Thamàs Fülöp, François Corbin, Artuela Çaku

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Alteration of Fatty Acid Profile in Fragile X Syndrome.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Amanda ToupinDepartment of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
Sérine BenachenhouDepartment of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
Armita AbolghasemiDepartment of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
Asma LarouiDepartment of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
Luc GalarneauDepartment of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
Thamàs FülöpResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada.
François CorbinDepartment of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
Artuela ÇakuDepartment of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada. Artuela.S.Caku@USherbrooke.ca.
Université de Sherbrooke · CACentre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal · CA

Funding

CIHR 412237
6 · The paper itself

Abstract

Fragile X syndrome (FXS) is the most prevalent monogenic cause of intellectual disability and autism spectrum disorder (ASD). Affected individuals have a high prevalence of hypocholesterolemia, however, the underlying mechanisms and the clinical significance remains unknown. We hypothesized that decrease in the plasma cholesterol levels is associated with an alteration of cholesterol content within the lipid rafts (LRs) which ultimately affects the clinical profile of FXS individuals. The platelets LRs were isolated by ultracentrifugation on sucrose gradient from 27 FXS and 25 healthy controls, followed by measurements of proteins, cholesterol, and gangliosides content. Autistic and adaptive behaviour of affected individuals were respectively assessed by the Social Communication Questionnaire and Adaptive Behavior Assessment System. Our results suggest a decrease in the cholesterol content of LRs in FXS individuals as compared to controls. As opposed to controls, LR cholesterol was significantly associated with plasma total cholesterol (r = 0.47; p = 0.042) in the FXS group. Furthermore, the correlation between LRs cholesterol and the clinical profile showed a significant association with autistic traits (r = - 0.67; p < 0.001) and adaptative behavior (r = 0.70; p < 0.001). These results support the clinical significance of LR cholesterol alterations in FXS. Further studies are warranted to investigate the implication of LRs in FXS pathophysiology and ASD.

Indexed as

Adaptation, PsychologicalAutism Spectrum DisorderBlood PlateletsCholesterolFragile X SyndromeHumansIntellectual DisabilityMembrane MicrodomainsSurveys and QuestionnairesCholesterol

Identifiers

PMID35190617
PMCPMC8861159
OpenAlexW4212914404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.